While the majority of infected individuals remain asymptomatic, 2–5% of HTLV-1-positive patients develop the fatal CD4+ T-cell malignancy Adult-T-cell Leukemia/Lymphoma (ATLL) [1,3,4,5,6]. Here, CD4 is linked to adult T-cell leukemia/lymphoma.